ãã€ãªå»è¬åäŒæ¥ã§ããã€ã³ãµã€ãã»ã³ãŒãã¬ãŒã·ã§ã³ã¯ãç±³åœããã³åœéçã«ç¬èªã®æ²»çè¬ã®çºèŠãéçºãããã³åååã«æ³šåããŠããŸããå瀟ã¯ã骚é«ç·ç¶çããã³çæ§å€è¡çã®æ²»çè¬ã§ãããžã£ã«ãã£ãæäººã®æ²»ççšç·ç¶èœçްè墿®å åå容äœãããŒãŒé»å®³å€ã§ããããã¶ã€ã¢ãæ
¢æ§éªšé«æ§çœè¡ç
ããã³ãã£ã©ãã«ãã£ã¢æè²äœéœæ§æ¥æ§ãªã³ãæ§çœè¡ç
ã®æ²»çè¬ã§ãããããŒãŒé»å®³å€ã§ããã¢ã€ã¯ã«ã·ã°ãæäŸããŠããŸããèšåºæ®µéã®è£œåã«ã¯ãã¹ããã€ãæµææ§ã®æ
¢æ§ç§»æ€ç察宿䞻ç
ïŒGVHDïŒã®æ²»çè¬ãšããŠç¬¬IIIçžèšåºè©Šéšäžã®ã«ããœãªããããæªæ²»çã®æ
¢æ§GVHDã®æ²»çè¬ãšããŠç¬¬IIIçžèšåºè©Šéšäžã®ã€ã¿ã·ããããªã©ããããŸããããã³èè±ãããè管ããã8p11骚é«å¢æ®æ§çå矀ãè
«çäžå¯ç¥è«ã®æ²»çè¬ãšããŠç¬¬IIçžèšåºè©Šéšäžã®ããã¬ãããã®éçºã«æºãã£ãŠããŸãããŸããæ¿Ÿèæ§ãªã³ãè
«ã蟺çžåž¯ãªã³ãè
«ããã³ãã«çްèãªã³ãè
«ã察象ãšãã第IIçžèšåºè©Šéšäžã®ããŒãµã¯ãªã·ãã®éçºã«ãåãçµãã§ããŸããããã«ãMSIé«äœåå®®å
èãããã¡ã«ã±ã«çްèãããèéããã察象ãšãã第IIçžèšåºè©Šéšããªãã³ã«éå°çްèèºããæ£è
ã察象ãšãã第IIçžèšåºè©Šéšäžã®ã¬ããã¡ã³ãªãããéçºããŠããŸããããã«ãã£ã¹ã»ã€ã³ã¿ãŒãã·ã§ãã«ã»ãã¡ãŒãã·ã¥ãŒãã£ã«ã«ã»ãªãããããã€ãŒã©ã€ãªãªãŒã»ã¢ã³ãã»ã«ã³ãããŒãã¢ãžã§ãã¹ã»ã€ã³ã¯ãã«ãªã»ã©ã»ãã€ãªãµã€ãšã³ã¹ã»ã€ã³ã¯ããã¯ããžã§ããã¯ã¹ã»ã€ã³ã¯ãã¡ã«ã¹NVãã·ãã¹ã»ãã¡ãŒãã·ã¥ãŒãã£ã«ã«ãºã»ã€ã³ã¯ãã€ããã³ãã»ãã€ãªããžã¯ã¹ã»ã€ã³ã¯ãã¶ã€ã»ã©ãã»ãªãããããã»ã¬ã³ã³ã¹ã»ã€ã³ã¯ãããã³ Nimble Therapeutics ãšã®ææºãããã³ MorphoSys AG ããã³ Xencor, Inc. ãšã®èšåºååã«ãããåçºæ§ãŸãã¯é£æ²»æ§ã®ã³ãŸãæ§å€§çްèå B 现èãªã³ãè
«ããã³åçºæ§ãŸãã¯é£æ²»æ§ã®æ¿Ÿèæ§ãªã³ãè
«ã®æ£è
ã察象ã«ãã¿ãã¡ã·ã¿ããããã©ã¢ã¿ãããã¬ããªãããã®äœµçšçæ³ãç ç©¶ããŠããŸããå瀟㯠1991 幎ã«èšç«ããããã©ãŠã§ã¢å·ãŠã£ã«ãã³ãã³ã«æ¬ç€Ÿã眮ããŠããŸãã